Skip to content

Can Europe reach the 90-90-90 target for HIV treatment by 2020?

Michel Kazatchkine presenting at EACS 2015. Image credit: mtvisuals.com

One third of people with HIV in US study are not virally suppressed on antiretroviral therapy

How do we treat the world? Experts discuss moving to universal HIV treatment

At least 25,000 people in the US may now be using PrEP

Increasing levels of engagement with care is key to controlling HIV epidemic in US

Thai testing campaign suggests how local cultures can influence testing behaviour

Spanish pharmacy HIV testing programme detects many new infections

STI clinic attendees have high HIV diagnosis rates in Netherlands, but many missed opportunities in primary care

Retention in pre-ART care can be boosted by monthly visits from volunteer support workers